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Abstract
Biosensor technology has developed extremely rapidly in recent years. This 
technology brings along precise measurements as well as specific measurements. 
Thanks to its ability to be miniaturized and be easily accessible to the end user, it 
is one-step ahead of other similar methods. The selectivity of biological molecules 
and the sensitivity of electrochemical methods enable the continuous evolvement 
of these new technologies. In this chapter, the use of nucleic acids as both recogni-
tion agents and target molecules, the way they are used in biosensor technology and 
their electrical properties are explained in detail with examples. Aptamers, which 
are synthetic nucleic acids, and their use in electrochemical biosensor systems 
with different electrochemical and immobilization methods have been compared 
extensively.
Keywords: biosensor, DNA, RNA, aptamer, electrochemistry, sensor, nanomaterials, 
impedance, differential pulse voltammetry, cyclic voltammetry, DNA tetrahedron, 
mediator
1. Introduction
Biosensor technology is a promising field where many outputs are continuously 
produced thanks to physicochemical techniques and biological materials developed 
every day. In this technology, a biological molecule interacts with the analyte on 
the biosensor and this generates a physicochemical signal which is detected by the 
transducer. Biosensor systems are divided into two classes in terms of biological 
molecules used, either catalytic-based which transforms the analyte or affinity-
based which binds the analyte directly [1]. In terms of physicochemical signal 
transmitter, it can be designed as electrochemical, optic or piezoelectric. Systems 
that are combined within also continue to be open to development today. For 
example, both electrochemistry and optical measurements can be made in spectro-
electrochemical techniques. Among these techniques, electrochemical systems [2], 
which are produced at low-costs without being interfered by the properties of the 
analyte solution, are used mostly.
The most important element of the biosensor is the biorecognition agent which 
shows the affinity for the analyte. These agents are of biological origin and are 
biomolecules with specific substrates such as proteins [3], enzymes [4], nucleic 
acids [5], antibodies [6], cells [7], cell surface channels. Biosensors can be designed 
by immobilizing these biomolecules on a suitable signal transmitter based on the 
Biosensor - Current and Novel Strategies for Biosensing
2
working principle. When selecting the biorecognition agent, the specimen containing 
the analyte to be measured and the characteristics of the reaction that will take place 
should be considered. It is desired that the biorecognition agent has a maximum  
activity and that it has a low degree of denaturation.
The living organism’s structural and functional strategy is hidden in its genes. 
The gene structure is based on the bases that form nucleic acids, which are divided 
into two main groups according to their functions, are deoxyribonucleic acid (DNA) 
and ribonucleic acids (RNA) [8]. DNA carries the genetic information in the double 
helix structure that includes adenine (A), guanine (G), cytosine (C) and thymine 
(T) bases. RNA has two main differences when compared to DNA, which are the 
inclusion of uracil (U) instead of T and the single stranded nucleic acid structure 
different from DNA. DNA’s double helix structure is formed with hydrogen bonds 
between the DNA bases of the complementary chains. In the same chain, ester bases 
between the 5 ‘OH group on the pentose sugar of a nucleotide and the 3’ OH group 
of the other nucleotide sugar form the single chain structure (Figure 1).
Thereby, U, A, G, C and T can be ordered in countless combinations to form 
genetic sequences. These sequences are copied and then transcribed in the ribo-
somes to take part in the synthesis of peptides and proteins by encoding one amino 
acid corresponding to all three bases.
Although they have different structures in different living organisms, the basic 
function of base sequences does not change. Erwin Chargaff showed that A-T and G-C 
base pairs in DNA sequences are mutually paired with hydrogen bond [9]. The impor-
tant point here is that the hydrogen bonds formed between DNA helixes directly affect 
the physical properties of DNA, since there are three hydrogen bonds between G-C, 
while there are two hydrogen bonds between A-T. If the G-C ratio is high, it requires 
more energetic power to separate the double helix. This is a considerable structural 
characteristic for the electrochemical techniques.
On the other hand, RNA is a single chain nucleic acid produced by using DNA 
sequences. Besides the three main types of RNA in protein encoding (mRNA, tRNA 
and rRNA), there are also other types of RNAs that serve in post-translational 
modifications in DNA replication or as regulators. For example, small nuclear RNA 
(snRNA) involved in RNA cleavage, guide RNA (gRNA) involved in CRISPR-Cas9 
system, micro RNA (miRNA), small interfering RNA (siRNA) and viral RNA. 
These different nucleic acids are worth to identify their function and structure [10].
Today, DNA or RNA analysis can be done quite precisely. Therefore, genetic 
sequences have a central role in diagnosis and treatment processes and they guide 
the scientists for development of new techniques. RNA and DNA sequences can 
be easily illuminated with polymerase chain reactions (PCR) and next-generation 
sequencing analyzers [11]. Like every method, these methods have limitations. For 
PCR, it is necessary to use consumables for reproduction and analysis of the nucleic 
acid sequences. This increases analysis costs and affects the analysis time. The dis-
advantages of the methods naturally make it inevitable to develop new and efficient 
methods. Although there are different nucleic acid analysis methods, simple and 
precise methods are needed. Bioelectronics systems are preferable as they are in the 
front line with their low cost, fast analysis time, minimum consumable require-
ment and lower margin of errors. Efficient properties of biological molecules with 
physicochemical transducer sensitivity increase the preferability. These basic mini 
analyzers are able to provide fast, low cost and precise analysis, based on the immo-
bilizing biological molecules on a physicochemical transducer. The term biosensor 
is developed by immobilizing a biomolecule of biological origin that provides the 
biochemical reaction on a transducer. In terms of classification, it can be divided 
into different areas according to both the working principle of the biomolecule and 
the working principle of the transducer.
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In electrochemical nucleic acid biosensor systems, the electrical signal occurs 
because of the interaction between the biorecognition agent and the analyte. As a 
result of the biochemical reaction, if an electron is formed, amperometric measure-
ment can be performed. If a molecule is formed it can be detected by potentiometric 
Figure 1. 
Representation of the hydrogen bonds between DNA chains.
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or direct affinity-based binding can be measured as impedimetric/capacitive. When 
there is no molecule being exposed, only affinity-based biosensor systems can be 
designed amperometrically. In this design, when the interaction between biomol-
ecules occurs, a secondary molecule (label) can generate an electrochemical signal. 
Measurements can be performed through the electrochemical activity of the label 
used here. Electrical conductivity is an extremely important parameter, especially 
in biosensor systems. Nucleic acids, on the other hand, can be considered as ideal 
transistors, because of their structure, they show conductive nanocable character-
istics and are very efficient in use in electrochemical biosensors in order to be found 
in many different conformations. The DNA helix has between 3.4-angstrom base 
pairs, and the aromatic ring structure facilitates electron flow. This structure, that is 
the closeness between the bases, is similar to the Z-directional space of graphite and 
provides conductivity. Moreover, the π electrons on DNA also help electrical con-
ductivity [10]. They help electrochemical conductivity due to structural variability.
On the other hand, beside the electroactivity of DNA, the electrochemical 
measurement method is important in the design of nucleic acid biosensors. Some 
electroactive secondary molecules can be used for the electrochemical detection. 
Mediators, which are frequently used in biosensor systems, can also be used to 
measure molecules that interact with DNA. Mediator is an intermediary molecule 
that facilitates electron exchange in an electrochemical reaction and lowers the 
reduction/oxidation potential of the detection system and also has regeneration 
potential [1]. The most important feature of a mediator is that it can signal in a low 
and narrow potential ranges. This feature increases the sensitivity of the biosensor 
since signaling of other electroactive species can be prevented in lower potentials.
Electroactive species can be determined using techniques such as differential 
pulse voltammetry (DPV) and cyclic voltammetry (CV) in studies that require 
the measurement of electroactive species, and the measurement of the amount 
of DNA through the reduction or oxidation of these species. The basic principle 
of the measurements is the presence of electroactive species on DNA (guanine 
base) or the formation of signals by binding some mediators or indicators to DNA. 
Indicators such as ruthenium complexes, ferrocene and methylene blue are often 
used for nucleic acid based biosensors. Measurement can be performed by chemi-
cally marking the DNA or RNA at the end or forming a complex with DNA helix. 
Measuring current generated by electroactive species in these electrochemical 
techniques is extremely important, but can also limit the effectiveness of measure-
ment systems. In other electrochemical measurement systems where mediators are 
not used, different electrochemical techniques that can measure nucleic acid binding 
or conformational changes may be used. These methods are performed in redox 
probe solutions to characterize electrode surface. Here, CV is capable of measuring 
physical changes on the surface with the help of a redox probe. When the sensitivity 
of CV in affinity based non-electroactive detections is insufficient, electrochemical 
impedance spectroscopy (EIS) or capacitance (C) measurement can also be used 
in affinity-based nucleic acid biosensors. These two methods are really sensitive 
methods to detect biomolecules, charge transfers and mass transfers with reaction 
kinetics and also are affected by electrode surface charges [12]. Therefore, nucleic 
acid length, base composition, and conformational changes after target molecule 
binding had to be considered before study design. Moreover, the negatively charged 
redox probe usage reduces the interference of the redox probe interaction between 
nucleic acid in the measurement.
Another advantage of nucleic acids is that there is no denaturation or loss of 
activity like proteins. The most important point to consider here is to take measures 
to reduce the effectiveness of DNase and RNase enzymes that break down nucleic 
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acids. Some examples of methods that can be used when designing a biosensor 
system with nucleic acids are given in the following pages.
2. Nucleic acids as biorecognition receptors and target
With 5 different base sequences on nucleic acids, the potential for an almost 
unlimited sequence is theoretically available. Their use as both a biorecognition 
agent and a target molecule to be analyzed is among its advantages. By its ability 
to form a complementary structure even within itself, it shows the feature of an 
analyte-biorecognition agent.
2.1 DNA and RNA usage in biosensor technology
In studies where DNA is used as a biorecognition agent, biosensor systems can 
be designed by measuring molecules that interact directly or indirectly with DNA. 
Especially in genetic analysis, DNA determinations have been performed based on 
complementary base pairings (Figure 2).
Chen et al. [13] developed a DNA biosensor whose signal was increased in 
triplicate for the determination of transgenic soybeans. Signal enhancement 
was performed as rolling circle amplification (RCA). In the biosensor system 
Chronocoulometry was used to detect DNAs via electrode surface charges. Firstly, 
Fe3O4@Au magnetic nanoparticles were produced and the electrode was modified 
with SH modified DNAs to capture the target DNA sequence. After this immobi-
lization on carbon electrode and incubated by dropping target DNA, complemen-
tary DNA forms a double structure with the target DNA. Afterwards, the double 
helix was cut and removed with ExoIII and 4 single-stranded ssDNA with a gold 
nanoparticle cube in the center was added to the free cutted ends, and binding was 
achieved with the help of Phi29 DNA polymerase and T4. [Ru(NH3)6]
3+, which 
forms a complex with anionic phosphates, is used as a complex mediator specifi-
cally bound on this quaternary structure. The amount of DNA was determined 
chronocoulometrically over the electrochemical signals generated by the ruthenium 
complex. A linear calibration curve was obtained between 10−16 and 10−7 M, and 
LOD was calculated as 4.5 × 10−17 M. Target DNA analysis took 2 hours. By the help 
of this complex DNA analysis, the authors managed to develop an ultra-sensitive 
system. Sensitivity is increased with the DNA immobilization steps used here. 
However, since the study requires a repetitive enzyme treatment, it seems costly 
and time consuming in developmental process.
Nucleic acid biosensors can also be developed by using enzymes used in DNA 
analysis. In recent years, studies using the CRISPR-Cas9 system are used in bio-
technological studies as a genetic editing molecule. Uygun et al. [14] developed 
an impedimetric graphene oxide electrode modified with CRISPR-dCas9 for the 
determination of the target circulating tumor DNA molecules containing the 
PIK3CA exon 9 mutation, which is used as a biomarker in breast cancer and is 
referred to as a liquid biopsy biomarker. In this study, deactivated Cas9 (dCas9) 
proteins without exonuclease activity, were used as biorecognition receptor by 
modifying them with a sgRNA that would recognize the target ctDNA sequence. 
Graphene oxide electrodes were modified with dCas9 and sgRNA, consequently. 
In this way, the modification for ctDNA analysis is completed. The short analysis 
time (40 seconds) needed was a great advantage. The impedimetric measurement 
method with a 1.92 nM LOD in the range of 2–20 nM ctDNA concentration has 
been developed.
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Because of the charges on the DNA, analysis of cations, where the bases show 
selectivity, can be detected. In another biosensor study, due to its negatively charged 
structure, the ability of chelating properties of DNAs for metal ions is used. Zhang 
Figure 2. 
Schematic representation of the DNA as biorecognition receptor.
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et al. [15] used DNA molecules for the determination of mercury ions. DNA probes 
modified with the DNA sulfur group formed a self-assembly monolayer on the 
gold electrode. Afterwards, the electrode modified with the reporter DNA, which 
has a gold nanoparticle in the center, was measured by binding mercury ions. Both 
impedance and CV were used in the study. The linear measuring range was set as 
1–200 nM and the LOD was calculated as 0.05 nM. By this study, thanks to the use 
of DNA molecules, the mercury molecule was determined with a relative standard 
deviation of 3% within real samples.
To observe the complementary base pairing and post translational modifica-
tions, secondary conjugates such as antibody or enzyme can be used in the DNA 
based biosensor studies. Huang et al. [16] developed a biosensor to determine DNA 
methylation levels. In this study, the methylation level was determined with the 
help of a bioconjugate modified by a secondary antibody. This conjugate is formed 
on graphene oxide layers that target CpG and have horseradish peroxidase (HRP)-
labeled anti-5-methylcytosine antibodies. The signal generated by HRP is directly 
proportional to the presence of methyl groups, and DPV was used in this enzymatic 
reaction-based study. Hydroquinone as a mediator, i.e. electron transmitter, also 
reduced the reaction voltage and made it more selective. Then, the measurement 
was carried out on the complex of the bioconjugate with cytosine containing 
methyl groups. While the biosensor reaches 1 fM LOD value, it can measure in the 
linear range between 1 fM and 10 nM. The preparation process of the biosensor 
took approximately 5 hours. In this study, since DNA methylation is performed by 
measuring the enzyme activity on the bioconjugate, the measurement efficiency is 
based on the performance of the antibody, enzyme and the mediator.
Jahandari et al. [17] developed a biosensor modified with gold nanoparticles 
for DNA-based Temodal (anticancer drug) determination. They also modified 
dsDNA molecules electrochemically on the gold nanoparticles deposited on the 
pencil graphite electrode. The binding of the Temodal to the DNA on the bio-
sensor was measured by DPV. Here, the main measurement is not the Temodal 
measurement directly. As the intercalator agent binds to the DNA, the reduction 
potential of the guanine base on the DNA decreases due to the amount of Temodal 
that is bound to DNA. Temodal performed intercalation by the interaction of the 
minor groove on the DNA. In this system with a maximum measurement time of 
8 minutes, a maximum recovery deviation of 5% was observed in real samples. 
Linearly, it showed 1 nM LOD with measurement performance between 5 nM and 
45 μM. The performance and sensitivity of this study are directly proportional to 
the presence of guanine bases. The base ratio on DNA is important in the design of 
such studies.
Ebrahimi et al. [18] determined cadmium ions using ethyl green (EG) on a 
simple DNA-based biosensor system. EG can be used as a hybridization indicator 
in DNA studies. Cadmium is known as a toxic heavy metal and this heavy metal 
measurement is especially important for biological samples. Cadmium destabilizes 
the double helix by forming a bond through the N7 atom of the guanine base on 
DNA. Similarly, in this study, measurement was performed using differential pulse 
voltammetry signals of EG. The signal generated by DPV is the oxidation signal 
that occurs as the result of the release of EG by destabilizing double helix. In other 
words, EG among the DNA helix is released as the result of the binding of cadmium 
to DNA, and it forms a destabilized DNA signal with cadmium. Measurement of 
cadmium ions showed 0.3 pM LOD with a linear measurement between 1 pM and 
1 nM and between 10 nM and 1 μM. The limitation of the study is the accumula-
tion performance of EG on DNA. The degree of this accumulation determines the 
sensitivity. It is difficult to determine the low amounts of cadmium in drinking 
water with a relative standard deviation of 8%.
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In biosensors developed with DNA, the properties of DNA hybrids can be used. 
Yang et al. [19] have developed an electrochemical biosensor for the determination 
of MCF-7 cells, which are breast cancer cells. In this biosensor, DNA molecules were 
used for modification. The system provided linear measurement between 100 and 
1 million cells in 1 mL and the LOD was found to be 80 cells/mL. The biosensor 
system was developed as a sandwich-type and the signal was made more sensitive 
with nanomaterials on antibodies labeled with DNA. With the 3D nanomaterials 
used in the design of the system, the modification steps are quite highly complex 
and difficult in terms of workload. In the study, the electrode was first modified 
with 3D-graphenes and then was modified with gold nanocages with antibody on 
the carbon nanotubes and immobilized on the electrode. DNA fragments labeled 
with a secondary antibody bonded on MCF-7 bound on these antibodies, and the 
measurement was performed with DPV. Here, MCF-7 measurement was performed 
by DNA hybridization, that is, by measuring the degree of binding of the comple-
ment bound to the ssDNA labeled with the last bound antibody.
Saeedfar et al. [20] developed a biosensor using multi-walled carbon nanotubes 
modified with gold nanoparticles to determine the sex of Arowana fish. The process 
of determining the sex of the Arowana fish before maturation is quite difficult. 
Arowana is an ancient and very expensive fish. This biosensor was developed as 
it is a very advantageous approach for the fish farming industry to distinguish 
the gender of the fish in time. For this, a hybridization-based approach has been 
adopted. Carbon nanotubes were used as a hybridization agent by complexing with 
ruthenium (III) chloride hex ammoniate in this study. DNA determination was 
performed between 10−21 M and 10−9 M and 1.55 × 10−21 M was the lowest detec-
tion limit.
Apart from DNA and proteins used in DNA determination, uncharged DNA 
variant known as Peptide Nucleic Acid (PNA) is also used. Unlike DNA, instead of a 
phosphate backbone, this molecule contains a backbone made of neutral amino acids. 
PNA of this nature can be used as potential probes for both DNA and RNA determi-
nation. The advantage of PNA is that it provides a great advantage in reducing the 
determination time. Tian et al. [21] used graphene field-effected transistors in their 
PNA-modified electrochemical biosensor study. In the DNA analysis study by mea-
suring the gate voltage, it reached the level of 0.1 aM LOD and performed between 0.1 
aM and 1 pM.
Due to their structural features, RNA biosensors can also be used in biosensor 
development, just like DNA biosensors. The structural differences of RNA with 
DNA were mentioned above. Apart from their metabolic functions, RNA and DNA 
are similar except for the difference in oxidation in ribose sugar. Studies have also 
been carried out which DNA and RNA can be used together in biosensor studies, 
especially using complementary DNAs for RNA analysis. In this section, RNA-based 
biosensors and types of studies are summarized.
Luo et al. [22] have developed an electrochemical DNA biosensor for exosomal 
miRNA analysis. The study was generally modified by adding a DNA probe modi-
fied with methylene blue (MB) over amino groups after the lysine amino acid 
was electrochemically coated on the glassy carbon electrode. Complementary to 
this probe, a ferrocene-modified secondary probe is attached. The biosensor was 
prepared for sample measurement by exosome extraction that releases miRNA to 
hybridize them to complementary chain and detected by labeled with Ferrocene 
(Fc). The variation of the Fc signal with the MB folded on itself indicates the 
miRNA and probe measurement, consequently. It shows performance at 2.3 fM 
level LOD and linear measurement range between 10 and 70 fM.
As a result, DNA and RNA have been used both as a recognition agent and as a 
target molecule with successful results. In some of these studies, the determination 
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was carried out by measuring a secondary molecule on the basis of DNA hybridiza-
tion. Besides, DNA analysis with the use of Cas proteins and DNA analysis with 
PNA were performed by using different methods and extremely low detection 
limits were reached.
2.2 Aptamers as synthetic biorecognition receptors
Aptamers have caught a very rapid trend after their discovery. These artificial 
nucleic acids are produced by the systematic evolution of ligands by exponential 
enrichment (SELEX) method [5]. By being artificially produced, they show affinity 
for a wide range of target molecules. They achieve this affinity with easy physical 
changes. Aptamer sequences designed in the correct sequence for the target molecule 
work by binding to the target site by undergoing conformational change when the 
target molecule approaches. The conformational change can be measured by using a 
label or surface resistance, shown in Figures 3 and 4, respectively.
Ohno et al. [23] developed a label-free immunosensor-based aptamer-modified 
graphene FET. The researchers, who modified the G-FET with IgE aptamers, deter-
mined IgG by measuring the gate voltage on the FET. With a protein concentration 
measurement between 0.29 and 340 nM, a LOD value of 0.29 nM was reached. 
47 nM isotherm value was observed as the Kd value. Since nonspecific binding of 
different proteins except this molecule was not observed.
In another study, Chen et al., [24] developed an aptamer-based biosensor for 
the electrochemical determination of Human epidermal growth factor (HER2). 
Differential pulse voltammetry was chosen as a measurement technique. In the 
study, after modifying the gold nanorod nanomaterials with palladium, they 
formed a bioconjugate for analysis by modifying it with an aptamer containing SH 
group and horse radish peroxidase (HRP). Later, they modified the gold electrode 
with DNA tetrahedrons. DNA tetrahedron is a nanoscale structure designed by 
using the complementary base pairing reactions of nucleic acids. They modified the 
single-stranded DNA aptamer from one corner of the DNA tetrahedron structure. 
Figure 3. 
Labeled-aptamer based electrochemical biosensor technology.
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DNA tetrahedron is preferred because of its mechanical structural rigidity and 
high affinity (5000 times higher for ssDNA aptamer). The DNA was dropped 
onto the tetrahedron-aptamer modified gold electrode, aptamer’s unbound ends 
were modified with BSA. After HER2 molecules were captured by the aptamer on 
the electrode, the bioconjugate was added on this modification and the biosensor 
was constructed???. HER2 measurement was performed indirectly through the 
conversion of HRP to hydrogen peroxide and the measurement of hydroquinone 
(mediator) added to the environment. In this study, researchers used the DNA 
tetrahedron structure and aptamer composite, thus HER2 recognition capacity 
was increased with this modification. The biosensor, with a working range of 
10–200 ng/mL, provided the opportunity to make the analysis in 60 minutes. 
LOD was found to be 0.15 ng/mL.
Apart from large proteins, aptamer molecules are also used to identify small 
molecules. Aptamer molecules are particularly useful for the determination of 
molecules which are extremely difficult and demanding to identify easily. Swensen 
et al. [25] conducted real-time cocaine measurement in their biosensor study. This 
determination was carried out in approximately one minute. The microfluidic chip 
has been modified with cocaine-specific aptamers for cocaine binding. One end of 
the aptamer is modified with methylene blue. The sample, injected into the micro-
fluidic chamber, was added to the fetal bovine serum with a flow, and the measure-
ment was performed by binding to the aptamer. Rapid measurement is important 
for the rapid determination of this drug, which has a half-life of 60–90 minutes 
in serum. Besides the speed advantage, this system has a 20 pM LOD with a linear 
detection range of 10–2000 μM.
Apart from organic molecules, aptamer-based biosensors have also been devel-
oped for the determination of ions. Radi et al. [26] developed a biosensor system for 
the aptamer-based potassium determination. The gold electrode was made ready 
Figure 4. 
Schematic representation of the impedimetric aptamer biosensor.
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for potassium ion measurement after being modified with aptamers with SH at 
one end and Fc at the other. The biosensor had a measurement limit between 0.1 
and 1 mM and reached a value of 0.015 LOD by using electrochemical impedance 
spectroscopy.
Besides the principle of binding aptamer molecules to a molecule, a bifunc-
tional aptamer-based biosensor for determination of adenosine and lysozyme was 
developed by Deng et al. [27]. In their study, they performed the determination of 
adenosine and lysozyme on DNA/DNA duplex. The gold electrode was first modi-
fied by a probe with SH group (adenosine selective) and then a secondary probe 
(lysozyme selective) attached to this probe, and the modification was completed 
with a DNA loaded nanomaterial with a central gold nanoparticle. Finally, ruthe-
nium complexes were added as electroactive species on this structure. After the 
primary probe captures adenosine with adenosine binding, the gold nanoparticle 
structure together with the secondary probe is separated from the biosensor. With 
lysozyme binding, the secondary structure is separated from the main structure by 
binding lysozyme. All these bonding and separation reactions were followed by the 
electrochemical activity of ruthenium complexes. Electrochemical measurement 
Electrochemical 
method
Biorecognition 
receptor
Target Linear range LOD Reference
Coul Phi29 DNA 
polymerase and T4
Transgenic 
soybeans DNA
10−16 and 10−7 M 4.5 × 10−17 M [6]
EIS CRISP-dCas9 PIK3CA 2–20 nM 1.92 nM [7]
CV DNA Hg2+ 1–200 nM 0.05 nM [8]
DPV DNA-(HRP)-
labeled IgG
DNA 
Methylation
1 fM–10 nM 1 fM [9]
DPV AuNPSs-DNA Temodal 5 nM–45 μM 1 nM [10]
DPV DNA-ethyl green Cd2+ 1 pM–1 nM 0.3 pM [11]
DPV DNA-antibody-
graphene
MCF-7 Cells 102–106 cells/mL 80 cells/mL [12]
DPV DNA-ruthenium Arowana fish 
gender (DNA)
10−21–10−9 M 1.55 × 10−21 M [13]
G-FET DNA PNA 0.1 aM–1 pM 0.1 aM [14]
DPV DNA-MB, DNA-Fc Exosomal 
miRNA
10–70 fM 2.3 fM [15]
G-FET IgG aptamer IgG 0.29–340 nM 0.29 nM [17]
DPV DNA tetrahedron 
– aptamer
HER2 10–200 ng/mL 0.15 ng/mL [18]
AC voltammetry Cocaine aptamer Cocaine 10–2000 μM 20 pM [19]
EIS 5′-ferrocene(Fc)–
DNA–SH-3′
K+ 0.1–1 mM 0.015 mM [20]
CV Adenosine-
lysozyme 
aptamers
Lysozyme
Adenosine
10–60 μg/mL
0.02–40 nM
0.01 μg/mL
0.02 nM
[21]
DPV: differential pulse voltammetry, EIS: electrochemical impedance spectroscopy, CV: cyclic voltammetry, Coul: 
coulometry, fc: ferrocene, PIK3CA: phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha, AuNPs: 
gold nanoparticles, G-FET: graphene field effect transistor, MB: methylene blue, HER2: human epidermal growth 
factor, AC: alternative current.
Table 1. 
Comparison of the nucleic acid based biosensors.
Biosensor - Current and Novel Strategies for Biosensing
12
was carried out by CV. Lysozyme and adenosine bifunctional biosensor reached the 
LOD limits of 0.01 μg/mL and 0.02 nM, respectively. Measurements were made 
between 0.02 and 40 nM for adenosine and 10–60 μg/mL for lysozyme.
With aptamer nucleic acids, target biomolecules can be easily identified. Although 
aptamer molecules work similarly to antibodies, they can easily be modified with a 
secondary biomolecule. Molecules that do not have denaturation problems unlike 
proteins can be very useful in the development of biosensors, especially in the 
development of electrochemical biosensors. Electrochemical activation of elec-
troactive species or direct aptamer binding to the target molecule can be measured 
impedimetrically. As a result, aptamer systems are suitable for affinity-based sensor 
development in biosensors (Table 1).
3. Conclusion
Biosensors are low cost analyzers with high potential to be miniaturized. They 
also provide short measurement time. Thanks to the numerous combinations of 
biorecognition receptor and transducers, biosensor systems can easily be adapted for 
the measurement of any kind of analyte. The biological activity of the biorecogni-
tion agent on the transducer is the critical element in a biosensor. Biomolecules with 
low probability of denaturation, adaptable to all kinds of measurements and strong 
electrical components should be selected for biosensor development. Nucleic acids 
meet the needs of biosensors at this point. They are advantageous biomolecules 
that can interact from metal ions to large proteins thanks to their multiple nega-
tive charges. Nucleic acids also have the potential to facilitate the determination of 
organic molecules, such as drugs and pesticides, which can enter between nucleic 
acid chains thanks to the electroactive guanine base in their structure. They can 
be used as simple biorecognition agents, similar to an unlimited antibody-antigen 
interaction, with the potential to be designed to synthetically show affinity for the 
target molecule. Another important feature of nucleic acids is the potential of their 
end portions to be modified by secondary signal transmitters without causing any 
deactivation. Apart from being both a biorecognition agent and an analyte molecule, 
their immobilization capacity also increases their usage and advantages. In conclu-
sion, the fact that they can be used as a material which provides stability and ease 
of modification for analysis in biosensor systems puts nucleic acids one step further 
among other biorecognition agents.
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